US2009076270A1PendingUtilityA1
Drying process for preparing crystalline solid famciclovir
Est. expiryMay 18, 2024(expired)· nominal 20-yr term from priority
C07D 473/32A61P 31/22
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a drying process for preparing crystalline solid famciclovir form I comprising the steps of: i) preparing a wet crystalline form of famciclovir; ii) drying the wet crystalline form of famciclovir at a temperature of below 50° C. until the crystalline form contains less than 15% (wt/wt) wetness; and iii) drying the wet crystalline form of famciclovir at a temperature of above 50° C. until the wet crystalline form of famciclovir contains less than 0.05% (wt/wt) water to obtain crystalline solid famciclovir form I.
Claims
exact text as granted — not AI-modified1 . Crystalline famciclovir containing less than about 1% (wt/wt) solvent.
2 . The crystalline famciclovir of claim 1 containing less than about 0.5% (wt/wt) solvent.
3 . The crystalline famciclovir of claim 2 containing less than about 0.05% (wt/wt) solvent.
4 . The crystalline form of claim 3 , wherein the crystalline form is famciclovir Form I.
5 . Crystalline famciclovir containing less than about 1% (wt/wt) solvent prepared by a process comprising:
a) providing a wet crystalline form of famciclovir containing about 40% (wt/wt) or less solvent; b) drying the wet crystalline form of famciclovir of step a) at a temperature of from about 30° C. to about 50° C. to obtain a wet crystalline form of famciclovir; and c) drying the wet crystalline form obtained from step b) at a temperature higher than 50° C. to obtain the crystalline form of famciclovir containing less than about 1% (wt/wt) solvent.
6 . Crystalline famciclovir containing less than about 0.5% (wt/wt) solvent prepared by a process comprising:
a) providing a wet crystalline form of famciclovir containing about 40% (wt/wt) or less solvent; b) drying the wet crystalline form of famciclovir of step a) at a temperature of from about 30° C. to about 50° C. to obtain a wet crystalline form of famciclovir; c) drying the wet crystalline form obtained from step b) at a temperature higher than 50° C. to obtain a crystalline form of famciclovir containing less than about 1% (wt/wt) solvent; and d) drying the crystalline form of famciclovir obtained in step c) at a temperature ranging from higher than about 50° C. to about 80° C. to obtain the crystalline form of famciclovir containing less than about 0.5% (wt/wt) solvent.
7 . Crystalline famciclovir containing less than about 0.05% (wt/wt) solvent prepared by a process comprising:
a) providing a wet crystalline form of famciclovir containing about 40% (wt/wt) or less solvent; b) drying the wet crystalline form of famciclovir of step a) at a temperature of from about 30° C. to about 50° C. to obtain a wet crystalline form of famciclovir; c) drying the wet crystalline form obtained from step b) at a temperature higher than 50° C. to obtain a crystalline form of famciclovir containing less than about 1% (wt/wt) solvent; and d) drying the crystalline form of famciclovir obtained in step c) at a temperature ranging from higher than about 50° C. to about 80° C. to obtain the crystalline form of famciclovir containing less than about 0.05% (wt/wt) solvent.
8 . The crystalline form of claim 7 , wherein the solvent is water and the crystalline form is famciclovir Form I.Join the waitlist — get patent alerts
Track US2009076270A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.